NCT06026722: SOMJEU

Behavioral and Cognitive Therapy for Insomnia in the Treatment of Pathological Gambling

Status unknown NA Last updated 7 September 2023

What this trial tests

NA trial testing cognitive behavioral therapy for insomnia in Gambling Disorder Treatment in 60 participants. Status unknown.

Timeline

1 September 2023

Primary endpoint
1 February 2025

1 October 2025

Quick facts

Lead sponsor	Assistance Publique - Hôpitaux de Paris
Phase	NA
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	single
Primary purpose	treatment
Enrollment	60
Start date	1 September 2023
Primary completion	1 February 2025
Estimated completion	1 October 2025
Sites	1 location across France

Drugs / interventions tested

• cognitive behavioral therapy for insomnia

Conditions studied

• Gambling Disorder Treatment — all drugs for Gambling Disorder Treatment →

Sponsor

Assistance Publique - Hôpitaux de Paris — full company profile →

Who can join

Adults 18 to 65, any sex, with Gambling Disorder Treatment. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Gambling is a public health risk. The wide panel of games available (poker, sport bets, scratch card games, slot machines, stock speculation …) and the advent of the Internet means that this behaviour is increasingly monitored on an epidemiological level, to the point where its pathological practice is now recognized in the DSM-5. Indeed, the scientific literature suggests a bidirectional link between use disorders and sleep disorders.

Sleep deprivation is known to lead to impaired judgment (risk-taking), increased sensitivity to reward, attentional difficulties and poor emotional management. The reverse has also been demonstrated: for example, playing at night has an impact on sleep quality, particularly in terms of difficulty falling asleep, ruminations about the game and a delay in the sleep-wake phase. Sleep disorders also affect patients undergoing withdrawal and/or cessation of a substance or behavior. This established link between addictions and circadian rhythms is important, since it is suggested that patients who are more impaired in both respects are more likely to relapse and respond less well to treatment.

In addictology, Behavioral and Cognitive Therapy for Insomnia (CBT-I) has proved effective in alcohol-dependent subjects in four studies. All reported a better quality of life (less depressive cognitions, better lifestyle) after CBT-I, although only one study reported a numerical reduction in consumption.The treatment of substance use disorders (AUD) remains limited : no pharmacological treatment has proved its worth, and the reference treatment remains mainly CBT. Despite the indisputable effectiveness of CBT, between 14% and 50% of patients are reported to have broken off from follow-up and care, and almost 90% of patients end up relapsing.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.